0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Kits > Hemagglutinin (HA) > RAS-A206

Influenza B/Victoria Lineage Viruses Hemagglutinin (HA) Specific ELISA Kit

For research use only.

Order Now

    Materials Provided
    IDComponentsSize
    RAS206-C01Pre-coated Anti-HA (Influenza B/Victoria Lineage) Antibody Microplate1 plate
    RAS206-C02HA (Influenza B/Victoria Lineage) Standard20 μg
    RAS206-C03HRP-Anti-HA (Influenza B/Victoria Lineage) Antibody20 μg
    RAS206-C0410×Washing Buffer 50 mL
    RAS206-C052×Dilution Buffer50 mL
    RAS206-C06Substrate Solution12 mL
    RAS206-C07Stop Solution7 mL
  • Background
    Influenza, commonly known as 'the flu', is an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. The virus is divided into three main types (Influenzavirus A, Influenzavirus B, and Influenzavirus C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle which makes it a great target for vaccine studies.
  • Application

    This kit is developed for specific quantitative detection of influenza B/Victoria lineage viruses HA protein in samples.

    It is for research use only.

  • Reconstitution
    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage
    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Assay Principles
    This assay kit employs a standard sandwich-ELISA format, providing a rapid detection of Influenza B/Victoria lineage viruses HA. The kit consists of Pre-coated Anti-HA (Influenza B/Victoria Lineage) Antibody Microplate and HA (Influenza B/Victoria Lineage) Standard,HRP-Anti-HA (Influenza B/Victoria Lineage) Antibody and buffers.

    Your experiment will include 5 simple steps:

    a) Bring all reagents and samples to room temperature (20℃-25℃) before use.

    b) Add your sample to the plate, take the HA (Influenza B/Victoria Lineage) as Control sample. The samples and Control sample are diluted by Dilution Buffer.

    c) Add the HRP-Anti-HA (Influenza B/Victoria Lineage) Antibody diluted by Dilution Buffer to the plate.

    d) Wash the plate and add TMB.

    e) Stop the substrate reaction by adding diluted acid. Absorbance (OD) is calculated as the absorbance at 450 nm minus the absorbance at 630 nm to remove background prior to statistical analysis. The OD Value reflects the amount of protein bound.

Typical Data Please refer to DS document for the assay protocol.
 Hemagglutinin (HA) TYPICAL DATA

For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.

 Hemagglutinin (HA) TYPICAL DATA

The kit has been tested to specifically identify Influenza B [Austria/1359417/2021 (B/Victoria lineage)] HA, and do not identify Influenza B [Phuket/3073/2013 (B/Yamagata lineage)] HA, Influenza A [Victoria/4897/2022 (H1N1)] HA, Influenza A [Wisconsin/67/2022(H1N1)] HA, Influenza A (A/Thailand/8/2022) & (A/Massachusetts/18/2022) HA (H3N2), Influenza A [A/Darwin/6/2021 (H3N2)] HA , Influenza A [A/Darwin/9/2021 (H3N2)] HA, Influenza A [A/District of Columbia/27/2023 (H3N2)] HA and Influenza A [A/Croatia/10136RV/2023 (H3N2)] HA.

  • Clinical and Translational Updates

Comments (0)


ETA des produits en stock: 2 jours ouvrables

Price(EUR) : €790.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:1 Details
  • Latest Research Phase:Phase 1 Clinical

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop

Laisser un message